Trial intelligence / Profile preview

Velphoro and impact on the oral cavity and gut microbiome

2017-003240-20Phase 4Terminated

Sponsor
RWTH Aachen University
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of iron sucrose in hyperphosphatemia (2 arms), sponsored by RWTH Aachen University. Primary endpoint: Shift in iron-dependent bacterial species. Started Sep 2017; status: terminated.

02

Drugs

iron sucrose
03

Conditions

hyperphosphatemia

Beyond the preview

Go deeper on 2017-003240-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003240-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call